ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Pan-European VC Redalpine closed a $250 million fund in Zurich, 25% larger than the 2024 RAC VII round. It targets seed and Series A investments for 15 to 20 startups focusing on robotics and AI for drug discovery, managing over $1.4 billion in assets.
Tap to vote and see what everyone thinks.
Summary by ByteBrief